Modification to deobligate FY06 funds

Ended Definitive Contract Awarded Last action

Contract number
00261200302D261035112
Awardee
Awarding agency
Obligated
$1,603,093

Award facts

Contract value 19% obligated
  • $7,935,141.00 Current, with exercised options
  • $8,606,292.00 Potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
Not on record
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers
Pricing
Cost No Fee
Place of performance
Houston, TX 77030, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action 10 -$385,132
Other Administrative Action 9 · This modification is created to allow a 12 month no cost extension. Contract completion date changed from 2/17/2009 to 2/17/2010. $0
Other Administrative Action 8 · This modification is created to revise article g.1 project officer. DR. Majorie perloff replaces DR. James a. Crowell. $0
Other Administrative Action 7 · Phase 1 pharmacodynamic study of COX-2 inhibition and aromatase activity in breast cancer, WS #48 $0
Other Administrative Action 6 $0
Other Administrative Action 5 $0
Funding Only Action 4 $671,121
Other Administrative Action 3 $0
Funding Only Action 2 $653,362
Supplemental Agreement for work within scope 1 $0
Original award $663,742
Show all 11

About this award

Written by GovTribe AI ·

This is a modification to a federal contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to The University of Texas MD Anderson Cancer Center (MD Anderson). The original contract was a definitive cost-no-fee contract awarded on February 15, 2003 with a ceiling value of $8,606,292. This modification is to deobligate FY06 funds. MD Anderson, a U.S. state government entity and academic medical center, has been the prime contractor as well as a subcontractor on numerous NIH, Department of Defense (DOD), and Department of Veterans Affairs (VA) grants and contracts related to cancer research, treatment, and support services. The contract did not have a set-aside designation.

Quick answers

Who was awarded contract 00261200302D261035112?

00261200302D261035112 was awarded to The Univeristy Of Texas M.d. Anderson Cancer Center by National Cancer Institute (National Institutes of Health) on February 15, 2003.

How much is contract 00261200302D261035112 worth?

The government has obligated $1,603,093 on 00261200302D261035112. Its current value, with exercised options, is $7,935,141. Its potential value, with all options, is $8,606,292.

Was contract 00261200302D261035112 competed?

The extent of competition for 00261200302D261035112 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login